CAMP vs LEN · rev $652.0K vs rev $34.19B
CAMP4 THERAPEUTICS CORPORATION (CAMP) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
LEN (LEN) common stock.
Latest reported CAMP revenue for 2024-12-31 was $652.0K. Net income was -$51.8M. Revenue was up 86.3% from 2023-12-31 to 2024-12-31. CAMP currently screens at market cap $215.0M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CAMP currently screens at market cap $215.0M. LEN currently screens at market cap $0.
Not investment advice. Open the CAMP and LEN stock pages for the full models.
Not investment advice.